Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts
Dec 22
Have your own idea? Try our Stock Screener
Danish (OMX) Biotech Industry Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies5
- 7D-2.1%
- 3M-7.7%
- 1Y-5.6%
- YTD-2.4%
Over the last 7 days, the Biotech industry has dropped 2.1%, driven by Genmab declining 2.5%. Meanwhile, Zealand Pharma actually outperformed within the industry, gaining 5.1% in the last week. However, the industry is down 5.6% over the past year. Looking forward, earnings are forecast to grow by 25% annually.
Industry Valuation and Performance
Has the Danish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 Jan 2025 | DKK 161.1b | DKK 26.0b | DKK 4.7b | 17x | 34.3x | 6.2x |
| Fri, 20 Dec 2024 | DKK 161.6b | DKK 26.0b | DKK 4.7b | 16.6x | 34.4x | 6.2x |
| Sun, 17 Nov 2024 | DKK 157.0b | DKK 26.0b | DKK 4.7b | 15.7x | 33.4x | 6x |
| Tue, 15 Oct 2024 | DKK 173.8b | DKK 25.5b | DKK 5.5b | 20.9x | 31.8x | 6.8x |
| Thu, 12 Sep 2024 | DKK 197.6b | DKK 25.5b | DKK 5.5b | 23.3x | 36.1x | 7.7x |
| Sat, 10 Aug 2024 | DKK 193.4b | DKK 24.8b | DKK 5.6b | 18.1x | 34.3x | 7.8x |
| Mon, 08 Jul 2024 | DKK 193.1b | DKK 24.8b | DKK 5.6b | 17.2x | 34.3x | 7.8x |
| Wed, 05 Jun 2024 | DKK 177.3b | DKK 24.8b | DKK 5.6b | 18.6x | 31.5x | 7.1x |
| Fri, 03 May 2024 | DKK 176.8b | DKK 23.9b | DKK 5.0b | 18.5x | 35.1x | 7.4x |
| Sun, 31 Mar 2024 | DKK 190.9b | DKK 23.9b | DKK 5.0b | 19.7x | 38x | 8x |
| Tue, 27 Feb 2024 | DKK 185.8b | DKK 22.8b | DKK 4.2b | 24.6x | 44.1x | 8.2x |
| Thu, 25 Jan 2024 | DKK 165.1b | DKK 23.3b | DKK 4.2b | 22.9x | 39.7x | 7.1x |
| Sat, 23 Dec 2023 | DKK 175.3b | DKK 23.3b | DKK 4.2b | 25.7x | 42.1x | 7.5x |
| Mon, 20 Nov 2023 | DKK 174.6b | DKK 23.3b | DKK 4.2b | 24.6x | 41.9x | 7.5x |
| Wed, 18 Oct 2023 | DKK 176.7b | DKK 22.0b | DKK 4.7b | 20.3x | 37.3x | 8x |
| Fri, 15 Sep 2023 | DKK 206.1b | DKK 22.0b | DKK 4.7b | 23.7x | 43.5x | 9.4x |
| Sun, 13 Aug 2023 | DKK 193.6b | DKK 20.6b | DKK 3.9b | 38.5x | 50x | 9.4x |
| Tue, 11 Jul 2023 | DKK 195.5b | DKK 19.5b | DKK 4.4b | 39.4x | 44.4x | 10x |
| Thu, 08 Jun 2023 | DKK 206.4b | DKK 19.5b | DKK 4.4b | 43x | 46.8x | 10.6x |
| Sat, 06 May 2023 | DKK 205.8b | DKK 17.9b | DKK 4.1b | 32.3x | 50.3x | 11.5x |
| Mon, 03 Apr 2023 | DKK 197.4b | DKK 17.9b | DKK 3.5b | 30.6x | 55.8x | 11x |
| Wed, 01 Mar 2023 | DKK 202.3b | DKK 17.3b | DKK 3.1b | 31.4x | 64.4x | 11.7x |
| Fri, 27 Jan 2023 | DKK 202.6b | DKK 14.7b | DKK 3.3b | 30.7x | 61.9x | 13.8x |
| Sun, 25 Dec 2022 | DKK 222.8b | DKK 14.7b | DKK 3.3b | 34.8x | 68.1x | 15.1x |
| Tue, 22 Nov 2022 | DKK 235.0b | DKK 14.7b | DKK 3.3b | 36.6x | 71.8x | 16x |
| Thu, 20 Oct 2022 | DKK 207.0b | DKK 12.4b | DKK 1.5b | 46.1x | 136.3x | 16.7x |
| Sat, 17 Sep 2022 | DKK 197.5b | DKK 12.4b | DKK 1.5b | 44.1x | 132.7x | 15.9x |
| Mon, 15 Aug 2022 | DKK 201.4b | DKK 12.2b | DKK 1.6b | 43.4x | 127.5x | 16.4x |
| Wed, 13 Jul 2022 | DKK 182.2b | DKK 11.1b | DKK 130.5m | 67.6x | 1396.3x | 16.5x |
| Fri, 10 Jun 2022 | DKK 157.2b | DKK 11.1b | DKK 130.5m | 58x | 1204.5x | 14.2x |
| Sun, 08 May 2022 | DKK 158.0b | DKK 10.7b | DKK 622.4m | 48.1x | 253.8x | 14.8x |
| Tue, 05 Apr 2022 | DKK 185.2b | DKK 10.7b | DKK 625.7m | 55.5x | 296x | 17.3x |
| Thu, 03 Mar 2022 | DKK 162.0b | DKK 10.4b | DKK 252.9m | 48.5x | 640.4x | 15.6x |
| Sat, 29 Jan 2022 | DKK 159.4b | DKK 9.8b | DKK 117.9m | 48.8x | 1351.6x | 16.2x |
Price to Earnings Ratio
1351.6x
Current Industry PE
- Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 34.3x which is lower than its 3-year average PE of 138x.
- The 3-year average PS ratio of 11.0x is higher than the industry's current PS ratio of 6.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 241% per year over the last three years.
- Revenues for these companies have grown 38% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Danish Healthcare industry?
| DK Market | -5.14% | |
| Healthcare | -8.30% | |
| Biotech | -2.15% | |
| Biotech | -2.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ZEAL Zealand Pharma | DKK 731.50 | 5.1% +DKK 2.5b | 63.1% | PS672.3x | |
| BAVA Bavarian Nordic | DKK 198.95 | 2.9% +DKK 362.6m | 24.7% | PE13.9x | |
| STRAP Strategic Partners | DKK 888.00 | 9.6% +DKK 3.2m | -29.2% | PB2.3x |